9 results match your criteria: "USA. Megan.Miller6@UHhospitals.org.[Affiliation]"
Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.
Ann Surg Oncol
October 2022
Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Lakeside 7009, Cleveland, OH, 44106-5047, USA.
Background: Guideline-consistent treatment (GCT) for inflammatory breast cancer (IBC) includes neoadjuvant chemotherapy (NAC), modified radical mastectomy (MRM), and radiation. We hypothesized that younger patients more frequently receive GCT, resulting in survival differences.
Methods: Using the National Cancer Database (2004-2018), female patients with unilateral IBC (by histology code and clinical stage T4d) were stratified by age (< 50, 50-65, > 65 years).
ASO Author Reflections: Inflammatory Breast Cancer: The Exception to De-escalation of Care for Older Women?
Ann Surg Oncol
October 2022
Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
ASO Author Reflections: Decisions, Decisions: Neoadjuvant Chemotherapy, Neoadjuvant Endocrine Therapy, or Primary Surgery?
Ann Surg Oncol
December 2022
Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes.
Ann Surg Oncol
October 2021
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Background: Neoadjuvant chemotherapy (NCT) is considered more effective in downstaging hormone receptor-positive (HR+) breast cancer than neoadjuvant endocrine therapy (NET), particularly in node-positive disease. This study compared breast and axillary response and survival after NCT and NET in HR+ breast cancer.
Methods: Based on American College of Surgeons Oncology Group (ACOSOG) Z1031 criteria, women age 50 years or older with cT2-4 HR+ breast cancer who underwent NET or NCT and surgery were identified in the National Cancer Database 2010-2016.
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer.
Ann Surg Oncol
December 2021
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Addressing Gender Disparity in Breast Cancer Care.
Ann Surg Oncol
October 2021
Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Lakeside 7009, Cleveland, OH, 44106-5047, USA.
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer.
Ann Surg Oncol
October 2021
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Article Synopsis
- A study compared how men and women receive neoadjuvant chemotherapy (NAC) for breast cancer and found that fewer men get this treatment.
- The research looked at 196,027 patients and discovered that 73% of men received chemotherapy compared to 84% of women, with only 26% of men getting NAC versus 45% of women.
- Both men and women had similar outcomes after treatment, but men often had more aggressive surgeries, suggesting that men should be given NAC more often when it's suitable.
ASO Author Reflections: Magnetic Seed Localization and Tracers Add Value to Multidisciplinary Breast Programs.
Ann Surg Oncol
June 2021
Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Hospital System Adoption of Magnetic Seeds for Wireless Breast and Lymph Node Localization.
Ann Surg Oncol
June 2021
Department of Surgery, University Hospitals, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Background: As an alternative to traditional wire localization, an inducible magnetic seed system can be used to identify and remove nonpalpable breast lesions and axillary lymph nodes intraoperatively. We report the largest single-institution experience of magnetic seed placement for operative localization to date, including feasibility and short-term outcomes.
Methods: Patients who underwent placement of a magnetic seed in the breast or lymph node were identified from July 2017 to March 2019.